SCHEMBL23636587

SCHEMBL23636587

CC(C)(C)c1cc(OCCCO)cc(/N=N/c2ccc(Cl)cc2[N+](=O)[O-])c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
MAPT P10636 5/20 0.35
LMNA P02545 5/20 0.35
SMN1; SMN2 Q16637 5/20 0.34
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
GALR3 O60755 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
MAPK1 P28482 2/20 0.34
ALPG P10696 1/20 0.34
S1PR4 O95977 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23636597 0.92 PSEN1 (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9817551 0.88 KMT2A (0.38) MAPTLMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL23636582 0.85 PIN1 (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8397410 0.84 ALDH1A1 (0.43) MAPTLMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL10340171 0.84 MEN1 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13021477 0.84 MEN1 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3480794 0.83 SMN1; SMN2 (0.34) MAPTLMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL6870910 0.80 MEN1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6870907 0.80 MEN1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7759721 0.80 MEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214321-A1 NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214321-A1 NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF SULT1A1, XDH, SULT2A1 PSEN1 2357/4885PSEN2 2616/4885APH1B 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.